Lazard's Stock: Analyst Confidence and Steady Growth
Update: 2025-10-13
Description
Lazard's stock saw a boost after KBW reaffirmed its Outperform rating, despite a lowered price target, signaling continued confidence in the financial firm. This followed news of growing assets under management and the addition of a biopharma expert to their Healthcare Advisory Group. While the stock remains below its 52-week high, steady growth and positive analyst sentiment make Lazard a financial stock to watch.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
